{{'Search' | translate}}
 

Coomassie Brilliant Blue G-250

Company: Bio-Rad Laboratories
Catalog#: 1610406
Bio-protocol()
Company-protocol()
Other protocol()

Expression and Purification of Recombinant Skd3 (Human ClpB) Protein and Tobacco Etch Virus (TEV) Protease from Escherichia coli
Author:
Date:
2020-12-05
[Abstract]  

Skd3 (encoded by human CLPB) is a mitochondrial AAA+ protein comprised of an N-terminal ankyrin-repeat domain and a C-terminal HCLR-clade nucleotide-binding domain. The function of Skd3 has long remained unknown due to challenges in purifying the protein to high quality and near homogeneity. Recently we described Skd3 as a human mitochondrial protein disaggregase that solubilizes proteins in the mitochondrial intermembrane space. This protocol overcomes the challenges associated with purifying Skd3 and allows for in depth in vitro study of Skd3 activity. Tobacco etch virus (TEV) protease is required in the purification of Skd3. Thus, we also describe how to purify high quality TEV protease for use in the purification of Skd3, other purification protocols, and in vitro assays requiring TEV

...
[摘要]  [摘要] Skd3(由人类CLPB编码)是一种线粒体AAA +蛋白,由N末端锚蛋白重复域和C末端HCLR分支核苷酸结合域组成。由于在纯化蛋白质达到高质量和接近均质性方面的挑战,Skd3的功能长期未知。最近,我们描述Skd3作为人类线粒体蛋白disaggregase ,在线粒体膜间间隙增溶蛋白。该协议克服了与纯化Skd3相关的挑战,并允许对Skd3活性进行深入的体外研究。Skd3的纯化需要烟草蚀刻病毒(TEV)蛋白酶。因此,我们还描述了如何净化高质量TEV蛋白酶可用于纯化Skd3,其他纯化方案以及需要TEV蛋白酶的体外测定。


[背景] Skd3是一种线粒体AAA +蛋白,与多系统线粒体疾病VII型3-甲基谷氨酸酸尿症(MGCA7)有关(Capo-Chichi等人,2015; Kanabus等人,2015; Saunders等人,, 2015; Wortmann等人,2015 ; Kiykim等人,2016 )。由于在体外研究Skd3的能力有限,因此对生物学功能和这些突变对Skd3活性的影响的研究仍难以捉摸(Cupo和Shorter,2020; ...

Purifying Properly Folded Cysteine-rich, Zinc Finger Containing Recombinant Proteins for Structural Drug Targeting Studies: the CH1 Domain of p300 as a Case Example
Author:
Date:
2017-09-05
[Abstract]  The transcription factor Hypoxia-Inducible Factor (HIF) complexes with the coactivator p300, activating the hypoxia response pathway and allowing tumors to grow. The CH1 and CAD domains of each respective protein form the interface between p300 and HIF. Small molecule compounds are in development that target and inhibit HIF/p300 complex formation, with the goal of reducing tumor growth. High resolution NMR spectroscopy is necessary to study ligand interaction with p300-CH1, and purifying high quantities of properly folded p300-CH1 is needed for pursuing structural and biophysical studies. p300-CH1 has 3 zinc fingers and 9 cysteine residues, posing challenges associated with reagent compatibility and protein oxidation. A protocol has been developed to overcome such issues by incorporating ... [摘要]  与共激活因子p300的转录因子缺氧诱导因子(HIF)复合物,激活缺氧反应途径并允许肿瘤生长。每个相应蛋白质的CH1和CAD结构域形成p300和HIF之间的界面。正在开发靶向和抑制HIF / p300复合物形成的小分子化合物,目的是减少肿瘤生长。研究配体与p300-CH1相互作用的高分辨NMR光谱是必要的,为了进行结构和生物物理学研究,需要净化大量正确折叠的p300-CH1。 p300-CH1具有3个锌指和9个半胱氨酸残基,构成与试剂相容性和蛋白氧化相关的挑战。已经开发了一种通过在表达过程中并入锌并简化纯化时间来克服这些问题的方案,导致适合于结构NMR研究的最佳折叠蛋白质(120mg / 4L表达介质)的高产率。已证实最终重组p300-CH1的结构完整性是使用一维1 H NMR光谱和圆二色性最优的。该方案适用于纯化其他含锌指蛋白质。
【背景】由于不适当的血管灌注,实体瘤的发展与缺氧区的发展有关。对于缺氧微环境,肿瘤细胞过表达低氧诱导因子(HIF),一种异二聚体转录因子家族(Semenza,2002; Brat和Van Meir,2004; Kaur等,2005)。 HIFs结合p300(一种转录共激活因子),形成诱导HIF靶基因的复合物,从而激活缺氧反应途径并促进肿瘤生长(Kasper and Brindle,2006; Liu,2008)。涉及HIF / p300蛋白 ...

Comments